|
Delayed
Nasdaq
12:09:50 21/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 10.09 USD | -0.39% |
|
-7.43% | +64.07% |
| 14/08 | ImmuCell Corporation, Q2 2026 Earnings Call, Aug 14, 2026 | |
| 14/08 | ImmuCell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMUCELL CORPORATION | Other Pharmaceuticals | -0.39% | -7.43% | +64.07% | +66.98% | +9.08% | 9.2Cr |  |  | |
- Stock Market
- Stocks
- ICCC Stock
- Charts ImmuCell Corporation
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
